{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:30:31Z","timestamp":1784910631239,"version":"3.55.0"},"reference-count":189,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.autrev.2016.03.003","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T02:15:17Z","timestamp":1457489717000},"page":"673-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Autoantibodies in inflammatory arthritis"],"prefix":"10.1016","volume":"15","author":[{"given":"P.","family":"Conigliaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.S.","family":"Chimenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Triggianese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Sunzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Novelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Perricone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0005","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.autrev.2014.08.012","article-title":"Anti-citrullinated peptides as autoantigens in rheumatoid arthritis-relevance to treatment","volume":"13","author":"Sakkas","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0010","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.autrev.2015.01.013","article-title":"Citrullination and autoimmunity","volume":"14","author":"Valesini","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0015","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nri2094","article-title":"Cytokines in the pathogenesis of rheumatoid arthritis","volume":"7","author":"McInnes","year":"2007","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0020","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.autrev.2015.07.006","article-title":"Gene\/environment interactions in the pathogenesis of autoimmunity: new insights on the role of toll-like receptors","volume":"14","author":"Gianchecchi","year":"2015","journal-title":"Autoimmun Rev"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0025","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1002\/art.1780301102","article-title":"The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis","volume":"30","author":"Gregersen","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0030","doi-asserted-by":"crossref","first-page":"3433","DOI":"10.1002\/art.21385","article-title":"Refining the complex rheumatoid arthritis phenotype based on specificity of the HLA-DRB1 shared epitope for antibodies to citrullinated proteins","volume":"52","author":"Huizinga","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.003_bb0035","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1146\/annurev.immunol.26.021607.090244","article-title":"Immunity to citrullinated proteins in rheumatoid arthritis","volume":"26","author":"Klareskog","year":"2008","journal-title":"Annu Rev Immunol"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0040","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1136\/ard.2006.067231","article-title":"HLA-DRB1*0404 is strongly associated with anticalpastatin antibodies in rheumatoid arthritis","volume":"66","author":"Auger","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0045","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/art.27594","article-title":"HLA-DR1001 presents \u201caltered-self\u201d peptides derived from joint-associated proteins by accepting citrulline in three of its binding pockets","volume":"62","author":"James","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00251-011-0528-6","article-title":"Genetics of rheumatoid arthritis: what have we learned?","volume":"63","author":"Bax","year":"2011","journal-title":"Immunogenetics"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0055","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.171.2.538","article-title":"Cutting edge: the conversion of arginine to citrulline allows for a high-affinity peptide interaction with the rheumatoid arthritis-associated HLA-DRB1*0401 MHC class II molecule","volume":"171","author":"Hill","year":"2003","journal-title":"J Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0060","first-page":"939","article-title":"The role of eight polymorphisms in three candidate genes in determining the susceptibility, phenotype, and response to anti-TNF therapy in patients with rheumatoid arthritis","volume":"30","author":"Ceccarelli","year":"2012","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0065","doi-asserted-by":"crossref","first-page":"R5","DOI":"10.1186\/ar2111","article-title":"The rheumatoid arthritis shared epitope increases cellular susceptibility to oxidative stress by antagonizing an adenosine-mediated anti-oxidative pathway","volume":"9","author":"Ling","year":"2007","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0070","doi-asserted-by":"crossref","first-page":"6359","DOI":"10.4049\/jimmunol.179.9.6359","article-title":"The rheumatoid arthritis shared epitope triggers innate immune signaling via cell surface calreticulin","volume":"179","author":"Ling","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0075","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.4049\/jimmunol.0904002","article-title":"Immune dysregulation by the rheumatoid arthritis shared epitope","volume":"185","author":"De Almeida","year":"2010","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0080","doi-asserted-by":"crossref","first-page":"48","DOI":"10.4049\/jimmunol.1202150","article-title":"An HLA-DRB1-coded signal transduction ligand facilitates inflammatory arthritis: a new mechanism of autoimmunity","volume":"190","author":"Holoshitz","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2016.03.003_bb0085","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-eular.5653","article-title":"Protective effect of HLA-DRB1*13 alleles during specific phases in the development of ACPA-positive RA","author":"van Heemst","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0090","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2011.04.021","article-title":"An overview on the genetic of rheumatoid arthritis: a never-ending story","volume":"10","author":"Perricone","year":"2011","journal-title":"Autoimmun Rev"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0095","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1038\/ng1205-1300","article-title":"Gaining insight into PTPN22 and autoimmunity","volume":"37","author":"Gregersen","year":"2005","journal-title":"Nat Genet"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0100","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1038\/nrrheum.2014.109","article-title":"PTPN22: the archetypal non-HLA autoimmunity gene","volume":"10","author":"Stanford","year":"2014","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0105","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1086\/468189","article-title":"PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis","volume":"77","author":"Carlton","year":"2005","journal-title":"Am J Hum Genet"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0110","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1086\/422827","article-title":"A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis","volume":"75","author":"Begovich","year":"2004","journal-title":"Am J Hum Genet"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0115","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1002\/art.21309","article-title":"Association between PADI4 and rheumatoid arthritis: a replication study","volume":"52","author":"Ikari","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0120","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/art.21536","article-title":"A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans","volume":"54","author":"Kang","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0125","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/s10165-012-0639-4","article-title":"PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis","volume":"23","author":"Hou","year":"2013","journal-title":"Mod Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.003_bb0130","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-015-0623-4","article-title":"Anti-citrullinated peptide\/protein antibody (ACPA)-negative RA shares a large proportion of susceptibility loci with ACPA-positive RA: a meta-analysis of genome-wide association study in a Japanese population","volume":"17","author":"Terao","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0135","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1136\/annrheumdis-2013-204591","article-title":"A genome-wide association study of rheumatoid arthritis without antibodies against citrullinated peptides","volume":"74","author":"Bossini-Castillo","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.003_bb0140","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1749-6632.2009.04806.x","article-title":"Seronegative autoimmune diseases","volume":"1173","author":"Alessandri","year":"2009","journal-title":"Ann N Y Acad Sci"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0145","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1002\/art.21419","article-title":"Regulation of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: contrasting effects of HLA-DR3 and the shared epitope alleles","volume":"52","author":"Irigoyen","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0150","doi-asserted-by":"crossref","first-page":"3058","DOI":"10.1002\/art.21302","article-title":"Association of HLA-DR3 with anti-cyclic citrullinated peptide antibody-negative rheumatoid arthritis","volume":"52","author":"Verpoort","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0155","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/art.24410","article-title":"Opposing effects of HLA-DRB1*13 alleles on the risk of developing anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis","volume":"60","author":"Lundstr\u00f6m","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0160","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/art.22704","article-title":"Association of a haplotype in the promoter region of the interferon regulatory factor 5 gene with rheumatoid arthritis","volume":"56","author":"Sigurdsson","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0165","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00296-010-1384-7","article-title":"The effects of shockwave on systemic concentrations of nitric oxide level, angiogenesis and osteogenesis factors in hip necrosis","volume":"31","author":"Wang","year":"2011","journal-title":"Rheumatol Int"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0170","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1136\/ard.2006.061390","article-title":"IRF5 rs2004640-T allele, the new genetic factor for systemic lupus erythematosus, is not associated with rheumatoid arthritis","volume":"66","author":"Garnier","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0175","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1002\/art.22271","article-title":"Analysis of IRF5 gene functional polymorphisms in rheumatoid arthritis","volume":"54","author":"Rueda","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0180","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1093\/hmg\/ddv455","article-title":"Functional implications of disease-specific variants in loci jointly associated with coeliac disease and rheumatoid arthritis","volume":"25","author":"Gutierrez-Achury","year":"2016","journal-title":"Hum Mol Genet"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0185","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.autrev.2016.01.001","article-title":"Smoke and autoimmunity: the fire behind the disease","volume":"15","author":"Perricone","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0190","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1080\/00039896.1983.10544001","article-title":"Complement activation by cigarette smoke condensate and tobacco infusion","volume":"38","author":"Perricone","year":"1983","journal-title":"Arch Environ Health"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0195","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1093\/rheumatology\/ken259","article-title":"A role for the aryl hydrocarbon receptor and the dioxin TCDD in rheumatoid arthritis","volume":"47","author":"Kobayashi","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0200","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.abb.2003.11.022","article-title":"Aryl hydrocarbon receptor-mediated posttranscriptional regulation of IL-1beta","volume":"422","author":"Henley","year":"2004","journal-title":"Arch Biochem Biophys"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0205","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1136\/annrheumdis-2013-204486","article-title":"Smoking induces transcription of the heat shock protein system in the joints","volume":"73","author":"Ospelt","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0210","doi-asserted-by":"crossref","first-page":"R133","DOI":"10.1186\/ar2022","article-title":"Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides","volume":"8","author":"Pedersen","year":"2006","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0215","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/art.21575","article-title":"A new model for an etiology of rheumatoid arthritis: smoking may trigger HLA-DR (shared epitope)-restricted immune reactions to autoantigens modified by citrullination","volume":"54","author":"Klareskog","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0220","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.autrev.2013.10.008","article-title":"Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies","volume":"13","author":"Shi","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.matbio.2006.10.008","article-title":"Carbamylation differentially alters type I collagen sensitivity to various collagenases","volume":"26","author":"Jaisson","year":"2007","journal-title":"Matrix Biol"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0230","doi-asserted-by":"crossref","first-page":"553","DOI":"10.3109\/08820137509055793","article-title":"Effect of carbamylation of lysine epsilon-amino groups on the activity of blood group specific glycoproteins","volume":"4","author":"Springer","year":"1975","journal-title":"Immunol Commun"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0235","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/CS20080322","article-title":"Myeloperoxidase-mediated lipoprotein carbamylation as a mechanistic pathway for atherosclerotic vascular disease","volume":"116","author":"Sirpal","year":"2009","journal-title":"Clin Sci (Lond)"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0240","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1016\/j.biochi.2012.06.032","article-title":"Carbamoylated free amino acids in uremia: HOCl generates volatile protein modifying and cytotoxic oxidant species from N-carbamoyl-threonine but not threonine","volume":"94","author":"Schreier","year":"2012","journal-title":"Biochimie"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0245","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1136\/annrheumdis-2013-204154","article-title":"Anti-carbamylated protein (anti-CarP) antibodies precede the onset of rheumatoid arthritis","volume":"73","author":"Shi","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0250","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/rheumatology\/kev285","article-title":"An immunochip-based interaction study of contrasting interaction effects with smoking in ACPA-positive versus ACPA-negative rheumatoid arthritis","volume":"55","author":"Jiang","year":"2016","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0255","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/art.39118","article-title":"Association of anti-Porphyromonas gingivalis antibody titers with nonsmoking status in early rheumatoid arthritis: results from the prospective French cohort of patients with early rheumatoid arthritis","volume":"67","author":"Seror","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0260","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1002\/art.38348","article-title":"Periodontitis and Porphyromonas gingivalis in patients with rheumatoid arthritis","volume":"66","author":"Mikuls","year":"2014","journal-title":"Arthritis Rheumatol."},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0265","first-page":"70","article-title":"Association of periodontal disease and tooth loss with rheumatoid arthritis in the US population","volume":"35","author":"de Pablo","year":"2008","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0270","doi-asserted-by":"crossref","first-page":"2662","DOI":"10.1002\/art.27552","article-title":"Peptidylarginine deiminase from Porphyromonas gingivalis citrullinates human fibrinogen and \u03b1-enolase: implications for autoimmunity in rheumatoid arthritis","volume":"62","author":"Wegner","year":"2010","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0275","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1002\/art.39491","article-title":"Antibodies to Porphyromonas gingivalis indicate interaction between oral infection, smoking and risk genes in rheumatoid arthritis etiology","volume":"68","author":"Kharlamova","year":"2016","journal-title":"Arthritis Rheumatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0280","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3109\/14397595.2013.854076","article-title":"Silica exposure is associated with an increased risk of developing ACPA-positive rheumatoid arthritis in an Asian population: evidence from the Malaysian MyEIRA case\u2013control study","volume":"24","author":"Yahya","year":"2014","journal-title":"Mod Rheumatol"},{"issue":"1 Suppl","key":"10.1016\/j.autrev.2016.03.003_bb0285","first-page":"11S","article-title":"Dysregulation of autoimmunity caused by silica exposure and alteration of Fas-mediated apoptosis in T lymphocytes derived from silicosis patients","volume":"24","author":"Otsuki","year":"2011","journal-title":"Int J Immunopathol Pharmacol"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0290","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1002\/art.11223","article-title":"Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis","volume":"48","author":"Rantap\u00e4\u00e4-Dahlqvist","year":"2003","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0295","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/art.1780280503","article-title":"When does rheumatoid disease start?","volume":"28","author":"Aho","year":"1985","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0300","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1136\/ard.2007.076679","article-title":"Duration of preclinical rheumatoid arthritis-related autoantibody positivity increases in subjects with older age at time of disease diagnosis","volume":"67","author":"Majka","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0305","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1186\/ar3237","article-title":"Antibodies of IgG, IgA and IgM isotypes against cyclic citrullinated peptide precede the development of rheumatoid arthritis","volume":"13","author":"Kokkonen","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0310","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1002\/art.20018","article-title":"Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors","volume":"50","author":"Nielen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0315","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1002\/art.37835","article-title":"Multiplex analyses of antibodies against citrullinated peptides in individuals prior to development of rheumatoid arthritis","volume":"65","author":"Brink","year":"2013","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0320","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1136\/annrheumdis-2011-200421","article-title":"The ACPA recognition profile and subgrouping of ACPA-positive RA patients","volume":"71","author":"Willemze","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0325","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1136\/ard.2009.124537","article-title":"Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis","volume":"69","author":"van der Woude","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0330","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0102163","article-title":"Antibodies specific for carbamylated proteins precede the onset of clinical symptoms in mice with Collagen induced arthritis","volume":"9","author":"Stoop","year":"2014","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0335","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1002\/art.30413","article-title":"Characterization of the anticollagen antibody response in a new model of chronic polyarthritis","volume":"63","author":"Conigliaro","year":"2011","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0340","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1136\/annrheumdis-2011-200205","article-title":"Undifferentiated arthritis characteristics and outcomes when applying the 2010 and 1987 criteria for rheumatoid arthritis","volume":"71","author":"Krabben","year":"2012","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0345","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1002\/art.20044","article-title":"Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study","volume":"50","author":"van Gaalen","year":"2004","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0350","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2011.76","article-title":"Anti-CCP antibodies: the past, the present and the future","volume":"7","author":"van Venrooij","year":"2011","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0355","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.autrev.2006.03.008","article-title":"Autoantibodies to citrullinated antigens in (early) rheumatoid arthritis","volume":"6","author":"van Venrooij","year":"2006","journal-title":"Autoimmun Rev"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0360","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1136\/ard.2008.105759","article-title":"Arthritis development in patients with arthralgia is strongly associated with anti-citrullinated protein antibody status: a prospective cohort study","volume":"69","author":"Bos","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0365","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1136\/ard.2010.132662","article-title":"The extent of the anti-citrullinated protein antibody repertoire is associated with arthritis development in patients with seropositive arthralgia","volume":"70","author":"van de Stadt","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.003_bb0370","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-207871","article-title":"Enriching case selection for imminent RA: the use of anti-CCP antibodies in individuals with new non-specific musculoskeletal symptoms \u2013 a cohort study","author":"Nam","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0375","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1002\/art.37830","article-title":"Anti-carbamylated protein antibodies are present in arthralgia patients and predict the development of rheumatoid arthritis","volume":"65","author":"Shi","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2016.03.003_bb0380","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13075-015-0536-2","article-title":"Anti-carbamylated protein antibodies in the pre-symptomatic phase of rheumatoid arthritis, their relationship with multiple anti-citrulline peptide antibodies and association with radiological damage","volume":"17","author":"Brink","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0385","doi-asserted-by":"crossref","first-page":"R76","DOI":"10.1186\/ar2995","article-title":"The likelihood of persistent arthritis increases with the level of anti-citrullinated peptide antibody and immunoglobulin M rheumatoid factor: a longitudinal study of 376 patients with very early undifferentiated arthritis","volume":"12","author":"Mjaavatten","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.03.003_bb0390","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s13075-015-0860-6","article-title":"The specificity of anti-carbamylated protein antibodies for rheumatoid arthritis in a setting of early arthritis","volume":"17","author":"Shi","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0395","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1136\/annrheumdis-2013-203650","article-title":"Anticarbamylated protein (anti-CarP) antibodies are present in sera of juvenile idiopathic arthritis (JIA) patients","volume":"72","author":"Muller","year":"2013","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0400","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1136\/ard.2010.138461","article-title":"2010 rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"69","author":"Aletaha","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0405","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0167-5699(00)01589-9","article-title":"The structure and origin of rheumatoid factors","volume":"21","author":"Sutton","year":"2000","journal-title":"Immunol Today"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0410","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.autrev.2007.02.017","article-title":"B cells in rheumatoid arthritis","volume":"7","author":"Bugatti","year":"2007","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0415","doi-asserted-by":"crossref","first-page":"R949","DOI":"10.1186\/ar1767","article-title":"Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis","volume":"7","author":"van der Helm-van Mil","year":"2005","journal-title":"Arthritis Res Ther"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0420","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1002\/art.24661","article-title":"Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts","volume":"60","author":"van der Woude","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0425","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0430","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1136\/ard.2003.012211","article-title":"Expression and activity of citrullinating peptidylarginine deiminase enzymes in monocytes and macrophages","volume":"63","author":"Vossenaar","year":"2004","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0435","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1046\/j.1365-2249.2000.01171.x","article-title":"In the rheumatoid pannus, anti-filaggrin autoantibodies are produced by local plasma cells and constitute a higher proportion of IgG than in synovial fluid and serum","volume":"119","author":"Masson-Bessi\u00e8re","year":"2000","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0440","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/1529-0131(200101)44:1<41::AID-ANR6>3.0.CO;2-0","article-title":"Secretion of anti-citrulline-containing peptide antibody by B lymphocytes in rheumatoid arthritis","volume":"44","author":"Reparon-Schuijt","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0445","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1529-0131(200001)43:1<155::AID-ANR20>3.0.CO;2-3","article-title":"The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic citrullinated peptide","volume":"43","author":"Schellekens","year":"2000","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0450","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.24720","article-title":"Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value","volume":"60","author":"Levesque","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0455","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.autrev.2012.05.007","article-title":"Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis","volume":"12","author":"Trouw","year":"2012","journal-title":"Autoimmun Rev"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0460","doi-asserted-by":"crossref","first-page":"R140","DOI":"10.1186\/ar4322","article-title":"ACPA fine-specificity profiles in early rheumatoid arthritis patients do not correlate with clinical features at baseline or with disease progression","volume":"15","author":"van Beers","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0465","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.clim.2015.04.005","article-title":"Biomarkers for rheumatoid and psoriatic arthritis","volume":"161","author":"Verheul","year":"2015","journal-title":"Clin Immunol"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0470","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1002\/art.1780380610","article-title":"Autoimmune response to the spliceosome. An immunologic link between rheumatoid arthritis, mixed connective tissue disease, and systemic lupus erythematosus","volume":"38","author":"Hassfeld","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0475","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/anr.1780321204","article-title":"Demonstration of a new antinuclear antibody (anti-RA33) that is highly specific for rheumatoid arthritis","volume":"32","author":"Hassfeld","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0480","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1136\/ard.2005.035691","article-title":"Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis","volume":"64","author":"Nell","year":"2005","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.003_bb0485","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2015-208529","article-title":"Antibodies to native and citrullinated RA33 (hnRNP A2\/B1) challenge citrullination as the inciting principle underlying loss of tolerance in rheumatoid arthritis","author":"Konig","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0490","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/art.22817","article-title":"Mutation and citrullination modifies vimentin to a novel autoantigen for rheumatoid arthritis","volume":"56","author":"Bang","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0495","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s10067-014-2544-z","article-title":"The performance of a point of care test for detection of anti-mutated citrullinated vimentin and rheumatoid factor in early rheumatoid arthritis","volume":"33","author":"Rojanasantikul","year":"2014","journal-title":"Clin Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0500","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00393-015-1598-x","article-title":"Diagnostic accuracy of anti-MCV and anti-CCP antibodies in rheumatoid arthritis: a meta-analysis","volume":"74","author":"Lee","year":"2015","journal-title":"Z Rheumatol"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0505","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2015-000180","article-title":"Predictive value of autoantibodies from anti-CCP2, anti-MCV and anti-human citrullinated fibrinogen tests, in early rheumatoid arthritis patients with rapid radiographic progression at 1year: results from the ESPOIR cohort","volume":"1","author":"Degbo\u00e9","year":"2015","journal-title":"RMD Open"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0510","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.3899\/jrheum.101086","article-title":"A comparison between IgG- and IgA-class antibodies to cyclic citrullinated peptides and to modified citrullinated vimentin in early rheumatoid arthritis and very early arthritis","volume":"38","author":"Sv\u00e4rd","year":"2011","journal-title":"J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0515","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1093\/rheumatology\/41.9.988","article-title":"Increased levels of autoantibodies against copper-oxidized low density lipoprotein, malondialdehyde-modified low density lipoprotein and cardiolipin in patients with rheumatoid arthritis","volume":"41","author":"Cvetkovic","year":"2002","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0520","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1002\/art.38969","article-title":"Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis","volume":"67","author":"Thiele","year":"2015","journal-title":"Arthritis Rheumatol."},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0525","doi-asserted-by":"crossref","first-page":"501","DOI":"10.3109\/07853890.2013.841322","article-title":"Plasma IgA antibody levels to malondialdehyde acetaldehyde-adducts are associated with inflammatory mediators, obesity and type 2 diabetes","volume":"45","author":"Vehkala","year":"2013","journal-title":"Ann Med"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0530","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1053\/he.2000.5373","article-title":"Detection of circulating antibodies against malondialdehyde-acetaldehyde adducts in patients with alcohol-induced liver disease","volume":"31","author":"Rolla","year":"2000","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0535","first-page":"969","article-title":"Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis","volume":"35","author":"Zhao","year":"2008","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0540","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/ard.2007.080267","article-title":"Serum IgG antibodies to peptidylarginine deiminase 4 in rheumatoid arthritis and associations with disease severity","volume":"67","author":"Halvorsen","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0545","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1136\/ard.2008.096917","article-title":"New autoantigens in rheumatoid arthritis (RA): screening 8268 protein arrays with sera from patients with RA","volume":"68","author":"Auger","year":"2009","journal-title":"Ann Rheum Dis"},{"issue":"186","key":"10.1016\/j.autrev.2016.03.003_bb0550","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0555","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028975","article-title":"Autoantibodies against the catalytic domain of BRAF are not specific serum markers for rheumatoid arthritis","volume":"6","author":"Li","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0560","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1002\/art.10472","article-title":"Epitope-specific recognition of type II Collagen by rheumatoid arthritis antibodies is shared with recognition by antibodies that are arthritogenic in collagen-induced arthritis in the mouse","volume":"46","author":"Burkhardt","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0565","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1002\/art.1780301215","article-title":"Evidence for local synthesis of antibodies to denatured collagen in the synovium in rheumatoid arthritis","volume":"30","author":"Rowley","year":"1987","journal-title":"Arthritis Rheum"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0570","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1002\/anr.1780320906","article-title":"Secretion of antibodies to types I and II collagen by synovial tissue cells in patients with rheumatoid arthritis","volume":"32","author":"Tarkowski","year":"1989","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0575","first-page":"575","article-title":"IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis","volume":"27","author":"Kim","year":"2000","journal-title":"J Rheumatol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0580","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/ard.2006.064782","volume":"66","author":"Mullazehi","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0585","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1002\/1529-0131(200104)44:4<761::AID-ANR132>3.0.CO;2-S","article-title":"The stress protein BiP is overexpressed and is a major B and T cell target in rheumatoid arthritis","volume":"44","author":"Bl\u00e4ss","year":"2001","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0590","doi-asserted-by":"crossref","first-page":"R191","DOI":"10.1186\/ar3520","article-title":"Detection of autoantibodies to citrullinated BiP in rheumatoid arthritis patients and pro-inflammatory role of citrullinated BiP in collagen-induced arthritis","volume":"13","author":"Shoda","year":"2011","journal-title":"Arthritis Res Ther"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0595","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1093\/rheumatology\/keh312","article-title":"Antibody response to the human stress protein BiP in rheumatoid arthritis","volume":"43","author":"Bodman-Smith","year":"2004","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0600","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/art.39054","article-title":"Proc Natl Acad Sci U S A. 2011 Autoantigen BiP-derived HLA-DR4 epitopes differentially recognized by effector and regulatory T Cells in rheumatoid arthritis","volume":"67","author":"Shoda","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"10","key":"10.1016\/j.autrev.2016.03.003_bb0605","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1136\/annrheumdis-2013-205109","article-title":"Anti-CarP antibodies in two large cohorts of patients with rheumatoid arthritis and their relationship to genetic risk factors, cigarette smoking and other autoantibodies","volume":"73","author":"Jiang","year":"2014","journal-title":"Ann Rheum Dis"},{"issue":"42","key":"10.1016\/j.autrev.2016.03.003_bb0610","doi-asserted-by":"crossref","first-page":"17372","DOI":"10.1073\/pnas.1114465108","article-title":"Autoantibodies recognizing carbamylated proteins are present in sera of patients with rheumatoid arthritis and predict joint damage","volume":"108","author":"Shi","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0615","doi-asserted-by":"crossref","first-page":"572","DOI":"10.3899\/jrheum.140767","article-title":"Anti-carbamylated protein antibodies are present prior to rheumatoid arthritis and are associated with its future diagnosis","volume":"42","author":"Gan","year":"2015","journal-title":"J Rheumatol"},{"issue":"6937","key":"10.1016\/j.autrev.2016.03.003_bb0620","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/nature01661","article-title":"Evolving concepts of rheumatoid arthritis","volume":"423","author":"Firestein","year":"2003","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0625","doi-asserted-by":"crossref","first-page":"85","DOI":"10.3109\/03009742.2011.617316","article-title":"Should rheumatoid factor in rheumatoid arthritis be sent to Davy Jones's Locker?","volume":"41","author":"Besada","year":"2012","journal-title":"Scand J Rheumatol"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0630","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1136\/ard.2003.014233","article-title":"Prediction of radiological outcome in early rheumatoid arthritis in clinical practice: role of antibodies to citrullinated peptides (anti-CCP)","volume":"63","author":"Forslind","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.003_bb0635","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/rheumatology\/kei203","article-title":"Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome","volume":"45","author":"Quinn","year":"2006","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.03.003_bb0640","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1136\/ard.2003.017574","article-title":"Rheumatoid factor and anticitrullinated protein antibodies in rheumatoid arthritis: diagnostic value, associations with radiological progression rate, and extra-articular manifestations","volume":"63","author":"De","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.003_bb0645","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00296-010-1671-3","article-title":"Anti-cyclic citrullinated peptide antibody predicts functional disability in patients with rheumatoid arthritis in a large prospective observational cohort in Japan","volume":"32","author":"Shidara","year":"2012","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2016.03.003_bb0650","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1186\/s13075-014-0483-3","article-title":"Rheumatoid factor and anti-citrullinated protein antibody positivity, but not level, are associated with increased mortality in patients with rheumatoid arthritis: results from two large independent cohorts","volume":"16","author":"Humphreys","year":"2014","journal-title":"Arthritis Res Ther"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0655","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1358\/dnp.2009.22.9.1437962","article-title":"The value of anti-cyclic citrullinated peptide antibodies in rheumatoid arthritis: do they imply new risk factors?","volume":"22","author":"L\u00f3pez-Longo","year":"2009","journal-title":"Drug News Perspect"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0660","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrrheum.2011.204","article-title":"The influence of ACPA status and characteristics on the course of RA","volume":"8","author":"Willemze","year":"2012","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0665","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1136\/ard.2004.029389","article-title":"Antibodies to citrullinated human fibrinogen (ACF) have diagnostic and prognostic value in early arthritis","volume":"64","author":"Nielen","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0670","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1007\/s00296-013-2799-8","article-title":"Clinical features and independent predictors in the further development of rheumatoid arthritis in undifferentiated arthritis","volume":"33","author":"Chen","year":"2013","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0675","doi-asserted-by":"crossref","first-page":"R16","DOI":"10.1186\/ar4148","article-title":"Anti-cyclic citrullinated peptide antibody titer predicts time to rheumatoid arthritis onset in patients with undifferentiated arthritis: results from a 2-year prospective study","volume":"15","author":"Bizzaro","year":"2013","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.autrev.2016.03.003_bb0680","article-title":"Anticarbamylated protein antibodies are associated with long-term disability and increased disease activity in patients with early inflammatory arthritis: results from the Norfolk Arthritis Register","author":"Humphreys","year":"2015","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0685","first-page":"824","article-title":"Anti-carbamylated protein antibodies in unaffected first-degree relatives of rheumatoid arthritis patients: lack of correlation with anti-cyclic citrullinated protein antibodies and rheumatoid factor","volume":"33","author":"Alessandri","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0690","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2012.02.015","article-title":"Diagnostic value of anti-mutated citrullinated vimentin in comparison to anti-cyclic citrullinated peptide and anti-viral citrullinated peptide 2 antibodies in rheumatoid arthritis: an Italian multicentric study and review of the literature","volume":"11","author":"Bartoloni","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.003_bb0695","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4137\/CMAMD.S4827","article-title":"Antibodies to mutated citrullinated vimentin in rheumatoid arthritis: diagnostic value, association with radiological damage and axial skeleton affection","volume":"3","author":"Mansour","year":"2010","journal-title":"Clin Med Insights Arthritis Musculoskelet Disord"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0700","doi-asserted-by":"crossref","first-page":"R100","DOI":"10.1186\/ar3825","article-title":"Anti-type II collagen antibodies are associated with early radiographic destruction in rheumatoid arthritis","volume":"14","author":"Mullazehi","year":"2012","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0705","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/03009740410005845","article-title":"Death rates and causes of death in patients with rheumatoid arthritis: a population-based study","volume":"33","author":"Sihvonen","year":"2004","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.autrev.2016.03.003_bb0710","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1136\/ard.2007.076521","article-title":"Incidence and predictors of severe extra-articular disease manifestations in an early rheumatoid arthritis inception cohort","volume":"66","author":"Turesson","year":"2007","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0715","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/art.24390","article-title":"Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis","volume":"61","author":"L\u00f3pez-Longo","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0720","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/ard.2008.088070","article-title":"Pretreatment serum levels of anti-cyclic citrullinated peptide antibodies are associated with the response to methotrexate in recent-onset arthritis","volume":"67","author":"Visser","year":"2008","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0725","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1002\/art.22525","article-title":"Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial","volume":"56","author":"van Dongen","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0730","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/art.23439","article-title":"Progression of joint damage in early rheumatoid arthritis: association with HLA-DRB1, rheumatoid factor, and anti-citrullinated protein antibodies in relation to different treatment strategies","volume":"58","author":"de Vries-Bouwstra","year":"2008","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0735","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1136\/annrheumdis-2015-207942","article-title":"Impact of baseline anti-cyclic citrullinated peptide-2 antibody concentration on efficacy outcomes following treatment with subcutaneous abatacept or adalimumab: 2-year results from the AMPLE trial","volume":"75","author":"Sokolove","year":"2016","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0740","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jbspin.2014.06.001","article-title":"High anti-CCP antibody titres predict good response to rituximab in patients with active rheumatoid arthritis","volume":"81","author":"Gardette","year":"2014","journal-title":"Joint Bone Spine"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0745","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0049-0172(73)90035-8","article-title":"Psoriatic arthritis","volume":"3","author":"Moll","year":"1973","journal-title":"Semin Arthritis Rheum"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0750","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.autrev.2015.08.003","article-title":"Auto-reactions, autoimmunity and psoriatic arthritis","volume":"14","author":"Chimenti","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.003_bb0755","doi-asserted-by":"crossref","DOI":"10.1002\/acr.22831","article-title":"The global prevalence of spondyloarthritis: a systematic review and meta-regression analysis","author":"Stolwijk","year":"2015","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5 Suppl 93","key":"10.1016\/j.autrev.2016.03.003_bb0760","first-page":"S26","article-title":"Peripheral joint involvement in psoriatic arthritis patients","volume":"33","author":"Acosta Felquer","year":"2015","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.003_bb0765","first-page":"1","article-title":"Psoriatic arthritis: complexities, comorbidities and implications for the clinic","volume":"28","author":"Haroon","year":"2016","journal-title":"Expert Rev Clin Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0770","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1159\/000345623","article-title":"Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study","volume":"225","author":"Esposito","year":"2012","journal-title":"Dermatology"},{"issue":"9","key":"10.1016\/j.autrev.2016.03.003_bb0775","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0780","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3899\/jrheum.141359","article-title":"Comorbidities associated with psoriatic arthritis compared with non-psoriatic spondyloarthritis: a cross-sectional study","volume":"43","author":"Haque","year":"2016","journal-title":"J Rheumatol"},{"issue":"2016 Jan 8","key":"10.1016\/j.autrev.2016.03.003_bb0785","article-title":"Group for research and assessment of psoriasis and psoriatic arthritis: treatment recommendations for psoriatic arthritis","author":"Coates","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0790","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1002\/art.21972","article-title":"Classification criteria for psoriatic arthritis: development of new criteria from a large international study","volume":"54","author":"Taylor","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0795","first-page":"304","article-title":"Clinical application of the CASPAR criteria for psoriatic arthritis compared to other existing criteria","volume":"28","author":"Congi","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.autrev.2016.03.003_bb0800","doi-asserted-by":"crossref","first-page":"823854","DOI":"10.1155\/2012\/823854","article-title":"Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study","volume":"2012","author":"Teoli","year":"2012","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/j.autrev.2016.03.003_bb0805","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1093\/rheumatology\/keg384","article-title":"A prospective, clinical and radiological study of early psoriatic arthritis: an early synovitis clinic experience","volume":"42","author":"Kane","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.autrev.2016.03.003_bb0810","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.autrev.2012.10.002","article-title":"Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways","volume":"12","author":"Chimenti","year":"2013","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2016.03.003_bb0815","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/s13075-015-0640-3","article-title":"Concepts of pathogenesis in psoriatic arthritis: genotype determines clinical phenotype","volume":"17","author":"FitzGerald","year":"2015","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0820","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/ard.2006.062042","article-title":"Ectopic lymphoid neogenesis in psoriatic arthritis","volume":"66","author":"Ca\u00f1ete","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2016.03.003_bb0825","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cei.12335","article-title":"Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment","volume":"177","author":"Conigliaro","year":"2014","journal-title":"Clin Exp Immunol"},{"issue":"4","key":"10.1016\/j.autrev.2016.03.003_bb0830","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s11926-011-0181-y","article-title":"Synovitis in psoriatic arthritis: immunohistochemistry, comparisons with rheumatoid arthritis, and effects of therapy","volume":"13","author":"van Kuijk","year":"2011","journal-title":"Curr Rheumatol Rep"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0835","first-page":"330","article-title":"Ultrasonographic wrist and hand abnormalities in early psoriatic arthritis patients: correlation with clinical, dermatological, serological and genetic indices","volume":"33","author":"Bandinelli","year":"2015","journal-title":"Clin Exp Rheumatol"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0840","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1093\/rheumatology\/keh686","article-title":"The clinical and genetic associations of anti-cyclic citrullinated peptide antibodies in psoriatic arthritis","volume":"44","author":"Korendowych","year":"2005","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0845","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/rheumatology\/ken456","article-title":"Very low prevalence of anti-CCP antibodies in rheumatoid factor-negative psoriatic polyarthritis","volume":"48","author":"Pasquetti","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.autrev.2016.03.003_bb0850","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10067-006-0214-5","article-title":"Anti-CCP antibodies in rheumatoid arthritis and psoriatic arthritis","volume":"26","author":"Inanc","year":"2007","journal-title":"Clin Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0855","first-page":"511","article-title":"Antibodies to cyclic citrullinated peptides in psoriatic arthritis","volume":"32","author":"Bogliolo","year":"2005","journal-title":"J Rheumatol"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0860","first-page":"930","article-title":"Anti-cyclic citrullinated peptide antibodies (CCP2) in patients with psoriatic arthritis","volume":"25","author":"Ou\u00e9draogo","year":"2007","journal-title":"Clin Exp Rheumatol"},{"issue":"3","key":"10.1016\/j.autrev.2016.03.003_bb0865","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1136\/ard.2005.040998","article-title":"Antibodies against cyclic citrullinated peptide (CCP) in psoriatic patients with or without joint inflammation","volume":"65","author":"Alenius","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"8","key":"10.1016\/j.autrev.2016.03.003_bb0870","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1136\/ard.2004.032177","article-title":"Anti-citrullinated peptide antibodies may occur in patients with psoriatic arthritis","volume":"64","author":"Vander Cruyssen","year":"2005","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1016\/j.autrev.2016.03.003_bb0875","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0134218","article-title":"Antinuclear antibodies in patients with psoriatic arthritis treated or not with biologics","volume":"10","author":"Silvy","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0880","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1111\/j.1365-2133.2011.10555.x","article-title":"Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction","volume":"165","author":"Hoffmann","year":"2011","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0885","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/j.jaad.2011.06.008","article-title":"The role of antinuclear autoantibodies in patients with psoriasis treated with anti-tumor necrosis factor-alpha agents: a retrospective long-term study","volume":"66","author":"Saraceno","year":"2012","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0890","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jaad.2013.03.020","article-title":"The significance of the development of antinuclear antibodies during infliximab treatment","volume":"69","author":"Saraceno","year":"2013","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.autrev.2016.03.003_bb0895","article-title":"The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study","author":"Hoxha","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/j.autrev.2016.03.003_bb0900","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115424","article-title":"Crossreactive autoantibodies directed against cutaneous and joint antigens are present in psoriatic arthritis","volume":"9","author":"Dolcino","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.autrev.2016.03.003_bb0905","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128262","article-title":"Gene Expression Profiling in peripheral blood cells and synovial membranes of patients with psoriatic arthritis","volume":"10","author":"Dolcino","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2016.03.003_bb0910","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3109\/15376516.2011.556155","article-title":"The effect of the uremic toxin cyanate (CNO-) on anaerobic cysteine metabolism and oxidative processes in the rat liver: a protective effect of lipoate","volume":"21","author":"Sokolowska","year":"2011","journal-title":"Toxicol Mech Methods"},{"key":"10.1016\/j.autrev.2016.03.003_bb0915","doi-asserted-by":"crossref","first-page":"474028","DOI":"10.1155\/2013\/474028","article-title":"Higher levels of autoantibodies targeting mutated citrullinated vimentin in patients with psoriatic arthritis than in patients with psoriasis vulgaris","volume":"2013","author":"Dalm\u00e1dy","year":"2013","journal-title":"Clin Dev Immunol"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0920","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/ard.62.5.455","article-title":"Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy","volume":"62","author":"Hoffman","year":"2003","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0925","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1093\/rheumatology\/kem324","article-title":"Anti-Saccharomyces cerevisiae antibodies (ASCA) in spondyloarthropathies: a reassessment","volume":"47","author":"Aydin","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"10.1016\/j.autrev.2016.03.003_bb0930","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s00296-014-3088-x","article-title":"An investigation into the relationship between anti-Helicobacter pylori and anti-Saccharomyces cerevisiae antibodies in patients with axial spondyloarthritis and Crohn disease","volume":"35","author":"Rodrigues","year":"2015","journal-title":"Rheumatol Int"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0935","doi-asserted-by":"crossref","first-page":"R166","DOI":"10.1186\/ar4350","article-title":"Elevated serum anti-flagellin antibodies implicate subclinical bowel inflammation in ankylosing spondylitis: an observational study","volume":"15","author":"Wallis","year":"2013","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"10.1016\/j.autrev.2016.03.003_bb0940","first-page":"920","article-title":"Antibodies to tissue transglutaminase and Saccharomyces cerevisiae in ankylosing spondylitis and psoriatic arthritis","volume":"31","author":"Riente","year":"2004","journal-title":"J Rheumatol"},{"issue":"12","key":"10.1016\/j.autrev.2016.03.003_bb0945","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00296-009-1186-y","article-title":"Antibodies to human tissue transglutaminase and alterations of vitamin D metabolism in ankylosing spondylitis and psoriatic arthritis","volume":"30","author":"Teichmann","year":"2010","journal-title":"Rheumatol Int"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300519?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997216300519?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T09:24:13Z","timestamp":1536917053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997216300519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":189,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S1568997216300519"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autoantibodies in inflammatory arthritis","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2016.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}